SM with an associated hematologic neoplasm (SM-ahn)

Clinical trials for SM with an associated hematologic neoplasm (SM-ahn) explained in plain language.

Never miss a new study

Get alerted when new SM with an associated hematologic neoplasm (SM-ahn) trials appear

Sign up with your email to follow new studies for SM with an associated hematologic neoplasm (SM-ahn), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for rare blood cancer: experimental drug targets mast cells

Disease control Recruiting now

This study tests an experimental drug called CGT9486 (bezuclastinib) in people with advanced systemic mastocytosis, a rare and serious blood disorder. The drug aims to control the disease by blocking a key protein that drives abnormal mast cell growth. About 140 adults with aggre…

Matched conditions: SM WITH AN ASSOCIATED HEMATOLOGIC NEOPLASM (SM-AHN)

Phase 2 • Sponsor: Cogent Biosciences, Inc. • Aim: Disease control

Last updated Sep 17, 2026 00:00 UTC

SM with an associated hematologic neoplasm (SM-ahn)

Get alerted when new SM with an associated hematologic neoplasm (SM-ahn) trials appear

New hope for rare blood cancer: experimental drug targets mast cells